Scientific work

Uzm. Dr. Aslı Geçgel

47 publications. The source of the information is stated next to each publication.

Back to profile

  1. FOLFOX Plus Bevacizumab Rechallenge Versus Regorafenib as Third-Line Treatment in Metastatic Colorectal Cancer: The Role of the Oxaliplatin-Free Interval

    Cancers, 2026

    DOI 10.3390/cancers18182987 PMID 42794953 Open-access full textSource: OpenAlex

  2. Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study

    Targeted Oncology, 2026

    DOI 10.1007/s11523-026-01261-w PMID 42907609 Source: OpenAlex

  3. Treatment Outcomes and Toxicity of Cisplatin–Etoposide-Based Regimens and Carboplatin–Paclitaxel as Adjuvant Chemotherapy for Ovarian Adult Granulosa Cell Tumors: A Multicenter Retrospective Cohort Study

    Cancers, 2026

    DOI 10.3390/cancers18182910 PMID 42794877 Open-access full textSource: OpenAlex

  4. Clinical Outcomes of Lenvatinib-Pembrolizumab in a High-Risk, Dual ICI-Refractory Melanoma Cohort

    Clinical Medicine Insights. Oncology, 2026

    DOI 10.1177/11795549261472694 PMID 42523965 Open-access full textSource: Europe PMC

  5. Is IMvigor011 a conventional adjuvant trial or a ctDNA-triggered preemptive treatment strategy?

    Future oncology (London, England), 2026

    DOI 10.1080/14796694.2026.2746184 PMID 42844909 Source: Europe PMC

  6. Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study

    Breast cancer (Dove Medical Press), 2026

    DOI 10.2147/bctt.s629176 PMID 42518661 Open-access full textSource: Europe PMC

  7. A hidden danger in cancer patients: intestinal parasites

    Turkish journal of medical sciences, 2026

    DOI 10.55730/1300-0144.6370 PMID 42677300 Open-access full textSource: Europe PMC

  8. Impact of prognostic nutritional index and geriatric nutritional risk index on prognosis in elderly patients with early-stage prostate cancer

    Frontiers in Nutrition, 2026

    DOI 10.3389/fnut.2026.1745718 PMID 41783818 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  9. Survival Patterns in Early-onset Colorectal Cancer Receiving Adjuvant Capecitabine Based Therapy

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-11-8 Open-access full textSource: OpenAlex

  10. Predicting 10-year survival in early and locally advanced breast cancer: prognostic value of nutritional status and body composition

    Nutrition, 2026

    DOI 10.1016/j.nut.2026.113133 PMID 41775036 Source: OpenAlex

  11. Methodological Considerations in the PENINSULA First-Line Pleural Mesothelioma Study: Endpoints, Imaging Review, and Safety

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.6142089 Open-access full textSource: OpenAlex

  12. Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026)

    Journal of Cancer Research and Clinical Oncology, 2026

    DOI 10.1007/s00432-026-06456-2 PMID 41874771 Open-access full textSource: OpenAlex

  13. Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma

    Cancer Investigation, 2026

    DOI 10.1080/07357907.2026.2739846 PMID 42831536 Open-access full textSource: OpenAlex

  14. Risk factors for dry eye disease in adult granulosa cell tumors: Implications for quality of life

    Ege Tıp Dergisi, 2026

    DOI 10.19161/etd.1802914 Open-access full textSource: OpenAlex

  15. 150P Adjuvant BEP/EP versus carboplatin-paclitaxel in adult granulosa cell tumor of the ovary: A multicenter analysis of survival and toxicity

    ESMO Open, 2026

    DOI 10.1016/j.esmoop.2026.108197 Open-access full textSource: OpenAlex

  16. HIV Seroprevalence and Screening Practices Among Cancer Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Study From Türkiye

    Journal of Clinical Practice and Research, 2026

    DOI 10.14744/cpr.2026.64997 PMID 42676394 Open-access full textSource: OpenAlex

  17. Kanserde Takip

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.3716 Open-access full textSource: OpenAlex

  18. Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14207376 PMID 41156245 Open-access full textSource: ORCID

  19. Prognostic Value of Preoperative Lymphocyte-to-Monocyte Ratio in Patients with Recurrent Colorectal Cancer

    Medicina, 2025

    DOI 10.3390/medicina61040707 PMID 40282998 9 citations (Europe PMC) Open-access full textSource: ORCID

  20. Is Mandard tumor regression grade scoring sufficient for locally advanced rectal cancer?

    Medical Science and Discovery, 2025

    DOI 10.36472/msd.v12i1.1228 Open-access full textSource: ORCID

  21. KRAS G12C Mutation Predicts Improved Survival in NSCLC Patients Receiving Immunotherapy: Insights from a Real-World Cohort

    Journal of clinical medicine, 2025

    DOI 10.3390/jcm14196826 PMID 41095904 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  22. Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland), 2025

    DOI 10.3390/diagnostics15243161 PMID 41464163 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  23. Prognostic Power of the Naples Score in Non-Small Cell Lung Cancer: Can Inflammation and Nutrition Predict Survival?

    Journal of clinical medicine, 2025

    DOI 10.3390/jcm14113715 PMID 40507476 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  24. Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy

    Medicina (Kaunas, Lithuania), 2025

    DOI 10.3390/medicina61091614 PMID 41011005 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  25. Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics

    Frontiers in Immunology, 2025

    DOI 10.3389/fimmu.2025.1616325 PMID 40642097 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  26. Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study

    BMJ Supportive & Palliative Care, 2025

    DOI 10.1136/spcare-2025-005991 PMID 41476001 2 citations (OpenAlex) Source: OpenAlex

  27. Malignant transformations in mature cystic teratomas: A case report and literature review

    Medicine International, 2025

    DOI 10.3892/mi.2025.251 PMID 40697355 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  28. Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

    Annals of Saudi Medicine, 2025

    DOI 10.5144/0256-4947.2025.249 PMID 40753462 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  29. GLR in Cholangiocarcinoma: A Practical Biomarker in Need of Validation

    Nutrition and Cancer, 2025

    DOI 10.1080/01635581.2025.2570558 PMID 41074758 1 citation (OpenAlex) Source: OpenAlex

  30. What impact does therapy selection have on the course of clinical outcomes for recurrent gliomas?

    The Annals of Clinical and Analytical Medicine, 2025

    DOI 10.4328/acam.22208 Open-access full textSource: OpenAlex

  31. Is the Combination of Pembrolizumab and Regorafenib the Beginning of a New Era in the Treatment of Metastatic Colorectal Cancer?

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-23 Open-access full textSource: OpenAlex

  32. Ten-Year Real-World Outcomes and Clinicopathologic Predictors of Recurrence in Adult Granulosa Cell Tumors: A Turkish Single-Center Experience

    Current Oncology, 2025

    DOI 10.3390/curroncol32090504 PMID 41002574 Open-access full textSource: OpenAlex

  33. 10-Year prognostic value of body composition in breast cancer: Implications for treatment and survival

    Clinical Nutrition ESPEN, 2025

    DOI 10.1016/j.clnesp.2025.07.395 Source: OpenAlex

  34. Body Mass Index as an Independent Prognostic Factor in Second-Line Nivolumab Therapy for Metastatic Clear Cell Renal Cell Carcinoma

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-11-10 Open-access full textSource: OpenAlex

  35. 393eP A viral footprint in tumor immunity: Anti-HBc IgG serostatus as a prognostic marker in melanoma

    Immuno-Oncology Technology, 2025

    DOI 10.1016/j.iotech.2025.101571 Open-access full textSource: OpenAlex

  36. Meningioma-Medulloblastoma-Ependimoma

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.3716.c6080 Source: OpenAlex

  37. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Open-access full textSource: OpenAlex

  38. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000038828 PMID 39058877 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. Assessment of Unwanted Side Effects of Vaccines in Cancer Patients: Where Do We Stand in Vaccination? Where Should Our Next Step Be?

    International Journal of Hematology and Oncology, 2024

    DOI 10.4999/uhod.247637 1 citation (OpenAlex) Open-access full textSource: ORCID

  40. Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib

    Balkan Medical Journal, 2024

    DOI 10.4274/balkanmedj.galenos.2024.2024-1-86 PMID 38572561 Open-access full textSource: ORCID

  41. Pigmentation of the Tongue, Nails, and Gingiva Following Adriamycin Therapy: A Literature Review and Clinical Insights

    Medical Science and Discovery, 2024

    DOI 10.36472/msd.v11i3.1137 Open-access full textSource: ORCID

  42. 16P Granulosa cell tumor of the ovary: 10-year follow-up data of 56 patients

    ESMO Open, 2024

    DOI 10.1016/j.esmoop.2024.102555 Open-access full textSource: ORCID

  43. Genetic Perspective of Breast Cancer Patients: Implications for Family Members

    Springer eBooks, 2024

    DOI 10.1007/978-3-031-75480-7_5 Source: ORCID

  44. Pembrolizumab Associated Autoimmune Diabetes Mellitus: Case Series

    Namık Kemal Tıp Dergisi, 2024

    DOI 10.4274/nkmj.galenos.2024.48726 1 citation (OpenAlex) Open-access full textSource: ORCID

  45. What impact does therapy selection have on the course of clinical outcomes for recurrent gliomas?

    MOJ Public Health, 2024

    DOI 10.15406/mojph.2024.13.00445 Source: OpenAlex

  46. Flavonoidler

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13887 Source: OpenAlex

  47. Living Donor Kidney Transplantation: Why Potential Donors and Recipients do not Achieve it. Malatya Algorithm

    Revista de Nefrologia, Dialisis Y Transplante, 2020

    Source: ORCID